Collins LL - Search Results

Year	Number of Results
1946	1
1951	1
1967	2
2000	1
2001	1
2002	4
2003	3
2004	1
2005	1
2007	2
2008	3
2009	2
2011	2
2012	2
2013	1
2014	1
2015	1
2017	3
2018	1
2023	1
2025	0

1

Vesicle trafficking and membrane remodelling in cytokinesis.

Neto H, Collins LL, Gould GW. Neto H, et al. Among authors: collins ll. Biochem J. 2011 Jul 1;437(1):13-24. doi: 10.1042/BJ20110153. Biochem J. 2011. PMID: 21668412 Review.

2

Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.

Klotz L, Breau RH, Collins LL, Gleave ME, Pickles T, Pouliot F, Saad F. Klotz L, et al. Among authors: collins ll. Can Urol Assoc J. 2017 Jan-Feb;11(1-2):16-23. doi: 10.5489/cuaj.4303. Can Urol Assoc J. 2017. PMID: 28443139 Free PMC article. Review.

3

The androgen receptor in spermatogenesis.

Collins LL, Lee HJ, Chen YT, Chang M, Hsu HY, Yeh S, Chang C. Collins LL, et al. Cytogenet Genome Res. 2003;103(3-4):299-301. doi: 10.1159/000076816. Cytogenet Genome Res. 2003. PMID: 15051951 Review.

4

Navigating later lines of treatment for advanced colorectal cancer - optimizing targeted biological therapies to improve outcomes.

Gill S, Dowden S, Colwell B, Collins LL, Berry S. Gill S, et al. Among authors: collins ll. Cancer Treat Rev. 2014 Dec;40(10):1171-81. doi: 10.1016/j.ctrv.2014.10.002. Epub 2014 Oct 16. Cancer Treat Rev. 2014. PMID: 25458604 Review.

5

Expression and activity of aryl hydrocarbon receptors in development and cancer.

Gasiewicz TA, Henry EC, Collins LL. Gasiewicz TA, et al. Among authors: collins ll. Crit Rev Eukaryot Gene Expr. 2008;18(4):279-321. doi: 10.1615/critreveukargeneexpr.v18.i4.10. Crit Rev Eukaryot Gene Expr. 2008. PMID: 18652561 Review.

6

Treatment of mCRPC in the AR-axis-targeted therapy-resistant state.

Chi K, Hotte SJ, Joshua AM, North S, Wyatt AW, Collins LL, Saad F. Chi K, et al. Among authors: collins ll. Ann Oncol. 2015 Oct;26(10):2044-56. doi: 10.1093/annonc/mdv267. Epub 2015 Jun 22. Ann Oncol. 2015. PMID: 26101426 Free article.

7

Rab11-FIP3 is a cell cycle-regulated phosphoprotein.

Collins LL, Simon G, Matheson J, Wu C, Miller MC, Otani T, Yu X, Hayashi S, Prekeris R, Gould GW. Collins LL, et al. BMC Cell Biol. 2012 Mar 8;13:4. doi: 10.1186/1471-2121-13-4. BMC Cell Biol. 2012. PMID: 22401586 Free PMC article.

8

Supplementary data: Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.

Klotz L, Breau RH, Collins LL, Gleave ME, Pickles T, Pouliot F, Saad F. Klotz L, et al. Among authors: collins ll. Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E62-E63. doi: 10.5489/cuaj.4494. Epub 2017 Feb 20. Can Urol Assoc J. 2017. PMID: 28443152 Free PMC article. Review. No abstract available.

9

Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials.

Mackey JR, Kerbel RS, Gelmon KA, McLeod DM, Chia SK, Rayson D, Verma S, Collins LL, Paterson AH, Robidoux A, Pritchard KI. Mackey JR, et al. Among authors: collins ll. Cancer Treat Rev. 2012 Oct;38(6):673-88. doi: 10.1016/j.ctrv.2011.12.002. Epub 2012 Feb 23. Cancer Treat Rev. 2012. PMID: 22365657

10

Syntaxin 16 is a master recruitment factor for cytokinesis.

Neto H, Kaupisch A, Collins LL, Gould GW. Neto H, et al. Among authors: collins ll. Mol Biol Cell. 2013 Dec;24(23):3663-74. doi: 10.1091/mbc.E13-06-0302. Epub 2013 Oct 9. Mol Biol Cell. 2013. PMID: 24109596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year